Yahoo Web Search

Search results

  1. AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.

    • R&D

      R&D - AstraZeneca - Research-Based BioPharmaceutical Company

    • Media

      Media - AstraZeneca - Research-Based BioPharmaceutical...

    • Sustainability

      Sustainability - AstraZeneca - Research-Based...

    • Partnering

      Joint research centres with leading academic institutes...

  2. en.wikipedia.org › wiki › AstraZenecaAstraZeneca - Wikipedia

    AstraZeneca plc (/ ˌ æ s t r ə ˈ z ɛ n ə k ə /) (AZ) is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

    • 6 April 1999; 24 years ago
    • Cambridge, England, UK
    • 83,500 (2022)
    • US$44.351 billion (2022)
  3. Mar 22, 2021 · Reuters. Results from the long-awaited US trial of the Oxford-AstraZeneca Covid vaccine are out and confirm that the shot is both safe and highly effective. More than 32,000 volunteers took...

  4. The OxfordAstraZeneca COVID‑19 vaccine, sold under the brand names Covishield [31] and Vaxzevria [1] [32] among others, is a viral vector vaccine for the prevention of COVID-19. It was developed in the United Kingdom by Oxford University and British-Swedish company AstraZeneca, [33] [34] [35] using as a vector the modified chimpanzee ...

    • Vaxzevria, Covishield
    • Viral vector
  5. People also ask

  6. Jun 3, 2021 · The AstraZeneca vaccine Vaxzevria is a vaccine against COVID-19. It's not yet approved for use in the United States. We explain how it works and more.

  7. The Oxford-AstraZeneca vaccine for Covid-19 is more rugged than the mRNA vaccines from Pfizer and Moderna. DNA is not as fragile as RNA, and the adenovirus’s tough protein coat helps protect...

  1. People also search for